Ghost Tree Capital, LLC Bicycle Therapeutics PLC Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $1.3 Million - $4.7 Million	-100,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $4.01 Million - $5.95 Million	100,000 New	100,000 $4.39 Million
Q4 2021 Feb 16, 2022	SELL	$41.7 - $61.14 $4.17 Million - $6.11 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $2.8 Million - $4.42 Million	-100,000 Reduced 50.0%	100,000 $4.16 Million
Q2 2021 Aug 11, 2021	BUY	$27.0 - $32.28 $1.35 Million - $1.61 Million	50,000 Added 33.33%	200,000 $6.07 Million

Q1 2021 May 14, 2021	BUY	$19.12 - $30.25 $2.87 Million - $4.54 Million	150,000 New	150,000 $4.48 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $600M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.